Company intelligence / Profile preview

Petri Bio

Boston, Massachusetts, United Statespetribio.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Petri Bio is developing novel therapeutics and healthcare products inspired by beneficial microbes, using a proprietary platform to discover and optimize bioactive compounds. The company is at the pre-clinical/pre-seed stage with no reported clinical results yet

Therapeutic areas: Other
Modalities: PeptidesSmall moleculeMicrobial therapy (therapeutics from gut microbes)
Industry: Biotech

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Petri Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Petri Bio.

Explore the full profile